Articles tagged with 'pancreatic cancer research' | Cedars-Sinai Medical Center

Cedars-Sinai Medical Center - Archive Pancreatic Cancer Research

2026
August
31,
2026
| 02:00 AM America/Los_Angeles
When added to standard chemotherapy, a clinical version of the dietary supplement L-glutamine improved survival in an early-phase trial of patients with advanced pancreatic cancer. The study, led by Cedars-Sinai Health Sciences University
Read more
May
31,
2026
| 05:00 AM America/Los_Angeles
A new medication could double survival time in patients with advanced pancreatic cancer, according to Phase III clinical trial results presented at the American Society of Clinical Oncology (ASCO) 2026 annual meeting and simultaneously published in
Read more
May
26,
2026
| 06:00 AM America/Los_Angeles
Physician-scientists from Cedars-Sinai Cancer and The Angeles Clinic and Research Institute, an affiliate of Cedars-Sinai, will present translational research designed to improve patient care and outcomes during the American Society of Clinical
Read more
March
04,
2026
| 06:00 AM America/Los_Angeles
Gastrointestinal cancer cases are expected to double worldwide by 2050, according to a multi-institutional study co-led by Cedars-Sinai. The projections, based on 2022 data and published in the journal Cancer, conclude that the biggest increases
Read more
March
03,
2026
| 06:00 AM America/Los_Angeles
A new tool co-developed by investigators from Cedars-Sinai Health Sciences University can predict which of two available chemotherapy options for pancreatic cancer would be more effective for an individual patient.If validated in further studies,
Read more
2024
November
26,
2024
| 07:00 AM America/Los_Angeles
Cedars-Sinai investigators who previously developed an imaging tool that used artificial intelligence (AI) to predict pancreatic cancer are now working to adapt that tool specifically for Black patients, who have disproportionately high rates of the
Read more
September
05,
2024
| 08:00 AM America/Los_Angeles
Staging of patients with early pancreatic cancer is inaccurate as much as 80% of the time, according to a new Cedars-Sinai Cancer study published in the peer-reviewed journal JAMA. The finding underscores the urgent need for advancements in
Read more
June
25,
2024
| 07:00 AM America/Los_Angeles
A new study published in the peer-reviewed journal Cancer Letters uncovered information about how the immune system can recognize and kill cancer cells, revealing a potential immunotherapy target for the treatment of pancreatic ductal
Read more